- Home
- MXCT vs IAE Comparison
MXCT vs IAE Comparison
Compare MXCT & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MXCT | IAE |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.5M | 80.3M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | MXCT | IAE |
|---|---|---|
| Price | $0.77 | $7.46 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 62.9K |
| Earning Date | 04-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.21% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $38,627,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.64 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.64 | $5.30 |
| 52 Week High | $3.49 | $8.30 |
Technical Indicators
Market Signals| Indicator | MXCT | IAE |
|---|---|---|
| Relative Strength Index (RSI) | 38.99 | 30.56 |
| Support Level | $0.75 | $7.40 |
| Resistance Level | $1.79 | $7.52 |
| Average True Range (ATR) | 0.06 | 0.12 |
| MACD | 0.03 | -0.08 |
| Stochastic Oscillator | 56.13 | 6.58 |
Price Performance
Historical ComparisonAbout MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.